Literature DB >> 20621541

Genealogical studies in LRRK2-associated Parkinson's disease in central Norway.

Krisztina K Johansen1, Kåre Hasselberg, Linda R White, Matthew J Farrer, Jan O Aasly.   

Abstract

The most common mutation related to Parkinson's disease (PD) is the p.G2019S mutation in the LRRK2 gene. Global population frequencies and crude estimates of haplotype conservation suggest most carriers are related. A total of 671 Norwegian PD patients and 215 of their family members were screened for the LRRK2 p.G2019S mutation. Twenty-one PD cases and 44 family members were positive for the mutation and all could be traced back to 10 different families. A genealogical study employed data from the Norwegian National Family Record Centre, local parish registers and population censuses. A common ancestor couple (living between 1580 and 1650) was found in six families, and two other families were associated by intermarriage. The remaining two families could not be traced back to either of these ancestors, though chromosome 12q12 haplotype analysis showed p.G2019S carriers shared alleles for 15 markers in the LRRK2 region. The study provides support for a common ancestor in Norwegian families with LRRK2 p.G2019S parkinsonism. The mutation was probably introduced to Norway through tradesmen from Europe. The extended pedigree that now links modern day carriers may help in mapping penetrance modifiers.
Copyright © 2010. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20621541     DOI: 10.1016/j.parkreldis.2010.05.005

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  7 in total

1.  LRRK2 parkinsonism in Tunisia and Norway: a comparative analysis of disease penetrance.

Authors:  Faycel Hentati; Joanne Trinh; Christina Thompson; Ekaterina Nosova; Matthew J Farrer; Jan O Aasly
Journal:  Neurology       Date:  2014-07-09       Impact factor: 9.910

2.  Exploring cancer in LRRK2 mutation carriers and idiopathic Parkinson's disease.

Authors:  Bjørg Johanne Warø; Jan O Aasly
Journal:  Brain Behav       Date:  2017-12-07       Impact factor: 2.708

Review 3.  Clinical and Imaging Markers of Prodromal Parkinson's Disease.

Authors:  Eldbjørg Hustad; Jan O Aasly
Journal:  Front Neurol       Date:  2020-05-08       Impact factor: 4.003

Review 4.  Inflammatory Diseases Among Norwegian LRRK2 Mutation Carriers. A 15-Years Follow-Up of a Cohort.

Authors:  Jan O Aasly
Journal:  Front Neurosci       Date:  2021-01-28       Impact factor: 4.677

5.  Genetic Identification in Early Onset Parkinsonism among Norwegian Patients.

Authors:  Emil K Gustavsson; Joanne Trinh; Marna McKenzie; Stephanie Bortnick; Maria Skaalum Petersen; Matthew J Farrer; Jan O Aasly
Journal:  Mov Disord Clin Pract       Date:  2017-05-23

6.  Elevated levels of cerebrospinal fluid α-synuclein oligomers in healthy asymptomatic LRRK2 mutation carriers.

Authors:  Jan O Aasly; Krisztina K Johansen; Gunnar Brønstad; Bjørg J Warø; Nour K Majbour; Shiji Varghese; Fatimah Alzahmi; Katerina E Paleologou; Dena A M Amer; Abdulmonem Al-Hayani; Omar M A El-Agnaf
Journal:  Front Aging Neurosci       Date:  2014-09-25       Impact factor: 5.750

7.  CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson's disease: a study in LRRK2 mutation carriers.

Authors:  Nour K Majbour; Jan O Aasly; Eldbjørg Hustad; Mercy A Thomas; Nishant N Vaikath; Naser Elkum; Wilma D J van de Berg; Takahiko Tokuda; Brit Mollenhauer; Henk W Berendse; Omar M A El-Agnaf
Journal:  Transl Neurodegener       Date:  2020-05-06       Impact factor: 8.014

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.